In conclusion, the present results suggest that the EPHB6 mutation promotes cancer cell proliferation and migration/invasion and induces CAM-DR, and these effects are mediated by the stabilization of EPHA2 and the activation of downstream JNK/CDH11/RhoA/FAK signaling. The gene discussed is EPHA2; the disease is cancer.